EMA accepts Mundipharma’s application for candidiasis drug rezafungin
Despite current treatments, the mortality rate for patients with invasive candidiasis remains high
Read More
Tag: Invasive candidiasis
Invasive candidiasis treatment rezafungin wins orphan drug status
IC is a severe and life-threatening form of Candida infection
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
